A phase IIa clinical trial in patients with vaginal mycosis to evaluate clinical efficacy, safety and tolerability and dose response relationship of topically administered ProF-001.

Registry ID

EUCTR2016-004268-21

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Profem GmbH

Start date

2017-03-23

Completion date

2018-07-30

Last update

2026-08-16

Conditions

• Vulvovaginal candidiasis

Summary

To determine dose-response in clinical efficacy of multiple dose administration of ProF-001 after vaginal administration at three dose levels compared to 1% vaginal clotrimazole cream

Locations

• , , Austria

View on source registry